Electrogram guidance: A method to increase the precision and diagnosticyieldofendomyocardial biopsy for suspectedcardiac sarcoidosisand myocarditis.

JACC: Heart Failure

Volumn 2, Issue 5, 2014, Pages 466-473

  Liang, Jackson J ^a   Hebl, Virginia B ^a   DeSimone, Christopher V ^a   Madhavan, Malini ^a   Nanda, Sudip ^a   Kapa, Suraj ^a   Maleszewski, Joseph J ^a   Edwards, William D ^a   Reeder, Guy ^a   Cooper, Leslie T ^a   Asirvatham, Samuel J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cardiac sarcoidosis; Cardiomyopathy; Electrogram; Endomyocardial biopsy; Myocarditis

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ABNORMAL LABORATORY RESULT; ADULT; ARTICLE; BIOPSY TECHNIQUE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ELECTROGRAM GUIDED ENDOMYOCARDIAL BIOPSY; ELECTROGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MALE; MAPPING CATHETER; MYOCARDIAL BIOPTOME; MYOCARDITIS; OUTCOME ASSESSMENT; PREDICTIVE VALUE; REFERENCE VALUE; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY;

EID: 84908062472     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2014.03.015     Document Type: Article

References (23)

1. Cooper L.T., Baughman K.L., Feldman A.M., et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. JAm Coll Cardiol 2007, 50:1914-1931.
2. Yancy C.W., Jessup M., Bozkurt B., et al. 2013 ACCF/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. JAm Coll Cardiol 2013, 62:e147-e239.
3. From A.M., Maleszewski J.J., Rihal C.S. Current status of endomyocardial biopsy. Mayo Clin Proc 2011, 86:1095-1102.
4. Deckers J.W., Hare J.M., Baughman K.L. Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy: a seven-year survey of 546 consecutive diagnostic procedures in a tertiary referral center. JAm Coll Cardiol 1992, 19:43-47.
5. Avella A., Pappalardo A., d'Amati G., et al. Endomyocardial biopsy guided by electroanatomic voltage mapping in arrhythmogenic right ventricular cardiomyopathy: a case report. JCardiovasc Electrophysiol 2007, 18:991-993.
6. Ejima K., Shoda M., Manaka T., Hagiwara N. Targeted endomyocardial biopsy using electroanatomical voltage mapping in the early stage of arrhythmogenic right ventricular cardiomyopathy. Europace 2009, 11:388-389.
7. Nery P.B., Keren A., Healey J., Leug E., Beanlands R.S., Birnie D.H. Isolated cardiac sarcoidosis: establishing the diagnosis with electroanatomic mapping-guided endomyocardial biopsy. Can J Cardiol 2013, 29:1015.e1-1015.e3.
8. Seizer P., Klingel K., Stickel J., et al. Left ventricular site-directed biopsy guided by left ventricular voltage mapping: a proof of principle. Int J Cardiol 2013, 168:3113-3114.
9. Kienzle M.G., Miller J., Falcone R.A., Harken A., Josephson M.E. Intraoperative endocardial mapping during sinus rhythm: relationship to site of origin of ventricular tachycardia. Circulation 1984, 70:957-965.
10. Cassidy D.M., Vassallo J.A., Miller J.M., et al. Endocardial catheter mapping in patients in sinus rhythm: relationship to underlying heart disease and ventricular arrhythmias. Circulation 1986, 73:645-652.
11. Marchlinski F.E., Callans D.J., Gottlieb C.D., Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation 2000, 101:1288-1296.
12. Bennett M.K., Gilotra N.A., Harrington C., et al. Evaluation of the role of endomyocardial biopsy in 851 patients with unexplained heart failure from 2000-2009. Circ Heart Fail 2013, 6:676-684.
13. Felker G.M., Thompson R.E., Hare J.M., et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. NEngl J Med 2000, 342:1077-1084.
14. Narula J., Khaw B.A., Dec G.W., et al. Diagnostic accuracy of antimyosin scintigraphy in suspected myocarditis. JNucl Cardiol 1996, 3:371-381.
15. Uemura A., Morimoto S., Hiramitsu S., Kato Y., Ito T., Hishida H. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 1999, 138:299-302.
16. Shields R.C., Tazelaar H.D., Berry G.J., Cooper L.T. The role of right ventricular endomyocardial biopsy for idiopathic giant cell myocarditis. JCard Fail 2002, 8:74-78.
17. Kandolin R., Lehtonen J., Kupari M. Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythm Electrophysiol 2011, 4:303-309.
18. Cooper L.T., Blauwet L.A. When should high-grade heart block trigger a search for a treatable cardiomyopathy?. Circ Arrhythm Electrophysiol 2011, 4:260-261.
19. Hauck A.J., Kearney D.L., Edwards W.D. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clinic Proc 1989, 64:1235-1245.
20. Kandolin R., Lehtonen J., Salmenkivi K., Räisänen-Sokolowski A., Lommi J., Kupari M. Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression. Circ Heart Fail 2013, 6:15-22.
21. Chimenti C., Frustaci A. Contribution and risks of left ventricular endomyocardial biopsy in patients with cardiomyopathies: a retrospective study over a 28-year period. Circulation 2013, 128:1531-1541.
22. Horowitz L.N., Kay H.R., Kutalek S.P., et al. Risks and complications of clinical cardiac electrophysiologic studies: a prospective analysis of 1,000 consecutive patients. JAm Coll Cardiol 1987, 9:1261-1268.
23. de Bakker J.M.T., Wittkampf F.H.M. The pathophysiologic basis of fractionated and complex electrograms and the impact of recording techniques on their detection and interpretation. Circ Arrhythm Electrophysiol 2010, 3:204-213.